SCHEMBL3846550

SCHEMBL3846550

CS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cc23)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CB P42338 2/20 0.35
MTOR P42345 2/20 0.35
PIK3CG P48736 2/20 0.35
CD38 P28907 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
HIF1A Q16665 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848501 0.84 CA12 (0.35) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL3846553 0.84 CD38 (0.31) CD38
SCHEMBL3846747 0.84 RPS6KB2 (0.39) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL3856217 0.83 CA12 (0.32) CD38CA12CA1CA2CA9
SCHEMBL3852886 0.82 CYP3A4 (0.33) CD38CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3846261 0.82 CA12 (0.34) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL3854489 0.81 PTGS2 (0.35) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL3853047 0.81 CA12 (0.32) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL3848504 0.81 CA12 (0.33) CA12CA1CA2CA9
SCHEMBL3854329 0.81 CA12 (0.31) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed